QURE (QURE) Stock Price & Analysis
QURE (QURE) fell 0.80% to USD 44.5 as of September 8, 2026 at 05:51 UTC, according to Nexqual real-time market data.
QURE last closed at USD 44.5; the session ranged USD 43.9–45.12 on volume of 991,475 shares. Market capitalization is —, with a 52-week range of USD 8.73–71.5 (NMS). Source: Nexqual, September 8, 2026 at 05:51 UTC.
Key Statistics (as of September 8, 2026 at 05:51 UTC)
| Price | USD 44.5 |
|---|---|
| Change | ▼ 0.80% (down) |
| Previous Close | USD 44.5 |
| Open | USD 44.5 |
| Day Range | USD 43.9 – 45.12 |
| 52-Week Range | USD 8.73 – 71.5 |
| Volume | 991,475 shares |
| Market Cap | — |
| Exchange | NMS |
Technical Analysis (QURE)
Nexqual's technical model rates QURE "BUY" based on 4 bullish and 2 bearish signals across 128 daily candles, as of September 8, 2026 at 05:51 UTC.
| Overall Signal | BUY |
|---|---|
| RSI (14) | 44.7 (neutral) |
| vs SMA50 | Above (USD 44.41) |
| MACD | 0.8 (positive) |
From QURE's Latest SEC 10-K Filing (filed 2026-03-02)
Source: SEC EDGAR 10-K. Curated by Nexqual.
Peers & Related Stocks
| Symbol | Name | Price | Change |
|---|---|---|---|
| RGNX | REGENXBIO Inc. | USD 8.94 | ▼ 6.88% |
| RARE | Ultragenyx Pharmaceutical Inc. | USD 15.3 | ▼ 42.33% |
| VYGR | Voyager Therapeutics, Inc. | USD 3.51 | ▼ 0.85% |
| PTCT | PTC Therapeutics, Inc. | USD 69.3 | ▼ 3.47% |
| MGNX | MacroGenics, Inc. | USD 4.4 | ▲ 1.85% |
Data source: Nexqual — real-time market data, technical indicators, analyst consensus, earnings, SEC EDGAR filings. Last updated: September 8, 2026 at 05:51 UTC. This page is informational and not investment advice.